New “THC in milligrams” limit in Oregon

Earlier this month, Oregon Governor Kate Brown signed into law HB 3000, A comprehensive bill covering a wide range of cannabis-related issues.Different from other cannabis bills Through the previous, HB 3000 is written to take effect after it is passed, so it is now a law. One of the important provisions of HB 3000 is to restrict the sale of certain cannabis consumer products, namely “adult cannabinoids” and “adult cannabis articles” to anyone under 21.

HB 3000 defines “cannabinoids for adults” as including but not limited to:

Tetrahydrocannabinol, artificial or naturally derived tetrahydrocannabinol, ?-8-tetrahydrocannabinol, ?-9-tetrahydrocannabinol, ?-8-tetrahydrocannabinol or ?-9-tetrahydrocannabinol The optical isomers and any reasonably determined to have intoxicating effects.

On the other hand, “adult use of marijuana items” means:

  1. Marijuana items;
  2. Industrial hemp commodities or products that meet the OAR 845-026-0300 standard; or
  3. An industrial hemp commodity or product that exceeds the greater of the following two:
    1. The concentration of total delta-9-tetrahydrocannabinol exceeds 0.3%; or
    2. The total delta-9-tetrahydrocannabinol concentration permitted by federal law.

In addition, the new Oregon law requires the Oregon Alcohol Control Board to cooperate with the Oregon Health Authority (“OHA”). From August 2 next week, the committee will be called the “Oregon Alcohol and Marijuana Board” (” OLCC”)”) and the Ministry of Agriculture (“ODA”) to determine the concentration of cannabinoids for adult cannabinoids for cannabis products or products that qualify as adult cannabis programs. The committee completed this work only four days after HB 3000 was promulgated.

according to Oar 845-026-0300, Industrial hemp goods or products are hemp articles for adults, if it:

  1. Any combination containing 0.5 mg or more:
    1. Tetrahydrocannabinol or tetrahydrocannabinol acid, including delta-9-tetrahydrocannabinol or delta-8-tetrahydrocannabinol; or
    2. Any other cannabinoids advertised by manufacturers or sellers have intoxicating effects;
  2. Contain any amount of artificially derived cannabinoids (IE, “A chemical substance produced by a chemical reaction that changes the molecular structure of any chemical substance from the Cannabis family Cannabis family”); or
  3. When tested under Oregon law, it has not been proven that its total delta-9-THC content is less than 0.5 mg.

The new regulations further stipulate that if a cannabis product or product meets the conditions for adult cannabis articles, it cannot be sold or delivered to people under 21 unless it is sold by an OLCC licensed cannabis retailer that is registered for sale or sale. Ship marijuana items to registered ID holders 18 years of age or older or anyone registered under the state’s medical marijuana program.

This 0.5 milligram limit is a major change because the amount of THC in milligrams (weight) that is determined in a cannabis product or product is different from the total percentage of THC contained in the product used.

To help cannabis companies determine whether their cannabis goods or products are below the 0.5 milligram threshold, three agencies in Oregon issued Joint guide Last week, it partially explained how to perform calculations. The working principle is as follows: The company must multiply the mass of “THC” (mg/g) on ??its product certificate of analysis (“COA”) by the weight of the items listed on the package. To put it more simply, if their cannabis item weighs 1 gram and the THC listed on the COA is 3.3 mg/g, then the total THC will be 3.3 mg (3.3 x 1), which means the cannabis item cannot be sold to minors People because it contains more than 0.5 mg of THC.

Although these new regulations prevent cannabis companies whose products exceed the 0.5 milligram threshold from selling their products to minors, they will not affect other sales and commercial activities. In other words, OLCC may eventually impose additional restrictions and requirements on these products, so cannabis companies should continue to closely monitor the Commission’s regulations to ensure continued compliance.

Source link